Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping ...

The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 ...

In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.

The Health Secretary’s 10-year plan includes proposals to bring down the cost of weight-loss drugs so more patients can get ...